PCI Pharma Services

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Targets set

SBTI ID

40010438

Informations générales

Localisation

United States of America

Northern America

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

10/07/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon FY2030

Statut

Targets set

Classification

1.5°C

Année cible

FY2030

Progression vers l'objectif0%
2015 (année de référence)FY2030
Objectifs à long terme (Long-Term)
Engagement de réduction des émissions à horizon FY2045

Statut

Targets set

Classification

1.5°C

Année cible

FY2045

Progression vers l'objectif0%
2015 (année de référence)FY2045
Description complète des objectifs

Overall Net-Zero Target: PCI Pharma Services commits to reach net-zero greenhouse gas emissions across the value chain by FY2045. Near-Term Targets: PCI Pharma Services commits to reduce absolute scope 1 and 2 GHG emissions 47.7% by FY2030 from a FY2023 base year. PCI Pharma Services also commits to reduce absolute scope 3 GHG emissions 25% by FY2030 from a FY2024 base year. Long-Term Targets: PCI Pharma Services commits to reduce absolute scope 1 and 2 GHG emissions 90% by FY2040 from a FY2023 base year. PCI Pharma Services also commits to reduce absolute scope 3 GHG emissions 90% by FY2045 from a FY2024 base year.

Net-Zero

Statut

Targets set

Année cible

FY2045

Progression0%
Business Ambition 1.5°C

Statut

BA1.5 member

Date d'engagement

29/09/2022

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

LEI

549300KFNOGZK02UIC66

Note

Expired commitment

Source : Science Based Targets initiative | Données publiques